C

Careium AB (publ)
STO:CARE

Watchlist Manager
Careium AB (publ)
STO:CARE
Watchlist
Price: 30.1 SEK -0.99% Market Closed
Market Cap: 732.2m SEK
Have any thoughts about
Careium AB (publ)?
Write Note

Careium AB (publ)
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Careium AB (publ)
Cash & Cash Equivalents Peer Comparison

Comparables:
EKTA B
S
SUS
CEVI
GETI B
ARJO B

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
C
Careium AB (publ)
STO:CARE
Cash & Cash Equivalents
kr31.5m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Cash & Cash Equivalents
kr2.8B
CAGR 3-Years
-8%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Cash & Cash Equivalents
kr667.1m
CAGR 3-Years
36%
CAGR 5-Years
81%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Cash & Cash Equivalents
kr137.7m
CAGR 3-Years
7%
CAGR 5-Years
-9%
CAGR 10-Years
9%
Getinge AB
STO:GETI B
Cash & Cash Equivalents
kr2.7B
CAGR 3-Years
-23%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Cash & Cash Equivalents
kr923m
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A

See Also

What is Careium AB (publ)'s Cash & Cash Equivalents?
Cash & Cash Equivalents
31.5m SEK

Based on the financial report for Dec 31, 2023, Careium AB (publ)'s Cash & Cash Equivalents amounts to 31.5m SEK.

What is Careium AB (publ)'s Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
-1%

Over the last year, the Cash & Cash Equivalents growth was -21%. The average annual Cash & Cash Equivalents growth rates for Careium AB (publ) have been -1% over the past three years .

Back to Top